InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,471.05
(
1.16%
)
US TECH 100
18,149.60
(
-0.16%
)
Dow Jones
40,829.59
(
1.20%
)
Brent Oil
71.08
(
-0.89%
)
Bitcoin
57,223.32
(
0.35%
)

Replies to post #57814 on DNAprint Genomics (DNAG)

Replies to #57814 on DNAprint Genomics (DNAG)
icon url

stockhlder101

02/24/07 4:20 AM

#57815 RE: ann441j #57814

Since m2gen is fully funded :-)) I have set up camp here and will buy from time to time on dips, if it actually does dip.
Because m2gen is alive, dnaprint will rock!
That is my opinion.
icon url

sam1933

02/24/07 5:52 AM

#57816 RE: ann441j #57814

DNAPrint also has two other pharmacogenomic products under development. It is working with the H. Lee Moffitt Cancer Center on the development of OVANOME(TM), a test for predicting an ovarian cancer patient's response to TAXOL/Carboplatin treatment, and STATINOME(TM), a test for predicting adverse response to cholesterol lowering medicines known as Statins. "Our DNA technology is advancing into new areas while we continue to develop our core genealogy business," Dr. Frudakis said. http://www.advfn.com/news_dnaprint-genomics-chairman-hector-gomez-tells-annual-meeting-that-company-...

Sam